Company intelligence / Profile preview

21 Invest

Treviso, Italy

Ownership: Private
Employees: ~50
Development stage: Other

Overview

21 Invest is a European investment group specializing in mid-market private equity with a dedicated healthcare fund, but is not itself a biotech or pharma operating company. It invests in companies across health, wellness, nutraceuticals, and other sectors, supporting growth, expansion, and value creation[2][10][13].

Industry: Investors

Beyond the preview

Go deeper on 21 Invest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 21 Invest.

Explore the full profile